lisaftoclax
ascentage pharmaceuticals
['hodgkin', 'lisaftoclax', 'apg-2575', 'lymphoma', 'ascent', 'ascentage pharma']
eha 2022 | ascentage pharma releases encouraging results of bcl-2 inhibitor lisaftoclax (apg-2575) in chinese patients with relapsed/refractory non-hodgkin lymphoma 
Politics around the globe